Michael H. Brent

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi et al. · The Lancet · 2023 · 263 citations · Full text

Clinical Epidemiology, Clinical Trials, Geographic Atrophy +5

Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort

Zhuo Chen, Miao Feng, Andrew D. Paterson et al. · Proceedings of the National Academy of Sciences · 2016 · 238 citations · Full text

Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study

Jonathan Q. Purnell, Barbara H. Braffett, Bernard Zinman et al. · Diabetes Care · 2017 · 112 citations · Full text

Faricimab Treat-and-Extend for Diabetic Macular Edema

Tien Yin Wong, Zdenka Hašková, Kemal Asik et al. · Ophthalmology · 2023 · 105 citations · Full text

Faricimab Treat-and-extend, Diabetic Retinopathy, Ocular Disease +3

Fixation Stability during Binocular Viewing in Patients with Age-Related Macular Degeneration

Luminita Tarita‐Nistor, Michael H. Brent, Martin J. Steinbach et al. · Investigative Ophthalmology & Visual Science · 2010 · 61 citations